Sorry, you need to enable JavaScript to visit this website.

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

A Phase 1/2, Placebo-Controlled, Randomized, Observer-Blind, Dose-Finding, First-in-Human Study to Describe the Safety, Tolerability, and Immunogenicity of an Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine in Healthy Older Adults

Category & Conditions: Vaccine-related Conditions
Medicine: PF-06928316 Identifier (NCT): NCT03572062
Protocol ID: C3671002
Open Plain Language Summary Result: Click here